InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
4.120
-0.350 (-7.83%)
Oct 29, 2026, 4:00 PM EDT - Market closed
InterCure Market Cap
InterCure has a market cap or net worth of $52.09 million as of October 29, 2026. Its market cap has decreased by 34.48% in one year.
Market Cap
52.09M
Enterprise Value
95.87M
1-Year Change
-34.48%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.77M to $52.09M, an increase of 2,846.00%. That is a compound annual growth rate of 23.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 52.09M | -6.14% |
| Dec 31, 2025 | 55.50M | -25.61% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BGM Group | 119.85M |
| Organogenesis Holdings | 116.12M |
| Cumberland Pharmaceuticals | 74.17M |
| Zhengye Biotechnology Holding | 68.24M |
| Citius Oncology | 64.62M |
| Talphera | 56.58M |
| SCYNEXIS | 37.81M |
| Incannex Healthcare | 32.87M |